Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KOPRAN. vs GUFIC BIOSCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KOPRAN. GUFIC BIOSCIENCE KOPRAN./
GUFIC BIOSCIENCE
 
P/E (TTM) x 30.9 32.6 94.6% View Chart
P/BV x 2.8 7.9 35.9% View Chart
Dividend Yield % 1.2 0.0 3,287.3%  

Financials

 KOPRAN.   GUFIC BIOSCIENCE
EQUITY SHARE DATA
    KOPRAN.
Mar-23
GUFIC BIOSCIENCE
Mar-23
KOPRAN./
GUFIC BIOSCIENCE
5-Yr Chart
Click to enlarge
High Rs327290 113.1%   
Low Rs96177 54.2%   
Sales per share (Unadj.) Rs114.371.2 160.4%  
Earnings per share (Unadj.) Rs5.68.2 68.7%  
Cash flow per share (Unadj.) Rs8.310.5 78.8%  
Dividends per share (Unadj.) Rs3.000.10 3,000.0%  
Avg Dividend yield %1.40 3,306.8%  
Book value per share (Unadj.) Rs91.135.9 253.9%  
Shares outstanding (eoy) m48.2196.94 49.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.93.3 56.5%   
Avg P/E ratio x37.528.4 132.0%  
P/CF ratio (eoy) x25.522.2 115.2%  
Price / Book Value ratio x2.36.5 35.7%  
Dividend payout %53.11.2 4,366.4%   
Avg Mkt Cap Rs m10,20522,620 45.1%   
No. of employees `000NANA-   
Total wages/salary Rs m499867 57.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5,5106,906 79.8%  
Other income Rs m3126 119.1%   
Total revenues Rs m5,5416,932 79.9%   
Gross profit Rs m5181,347 38.5%  
Depreciation Rs m127223 57.1%   
Interest Rs m6182 74.0%   
Profit before tax Rs m3611,067 33.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m88270 32.7%   
Profit after tax Rs m272797 34.2%  
Gross profit margin %9.419.5 48.2%  
Effective tax rate %24.525.3 96.7%   
Net profit margin %4.911.5 42.8%  
BALANCE SHEET DATA
Current assets Rs m3,9914,641 86.0%   
Current liabilities Rs m1,7702,882 61.4%   
Net working cap to sales %40.325.5 158.3%  
Current ratio x2.31.6 140.0%  
Inventory Days Days1135 30.1%  
Debtors Days Days1,0771,086 99.2%  
Net fixed assets Rs m2,5063,961 63.3%   
Share capital Rs m48297 497.3%   
"Free" reserves Rs m3,9103,381 115.7%   
Net worth Rs m4,3923,478 126.3%   
Long term debt Rs m1791,907 9.4%   
Total assets Rs m6,4978,602 75.5%  
Interest coverage x6.914.0 49.6%   
Debt to equity ratio x00.5 7.4%  
Sales to assets ratio x0.80.8 105.6%   
Return on assets %5.110.2 50.2%  
Return on equity %6.222.9 27.1%  
Return on capital %9.221.3 43.2%  
Exports to sales %44.712.5 359.0%   
Imports to sales %10.139.3 25.7%   
Exports (fob) Rs m2,464860 286.4%   
Imports (cif) Rs m5582,716 20.5%   
Fx inflow Rs m2,464860 286.4%   
Fx outflow Rs m6242,716 23.0%   
Net fx Rs m1,840-1,855 -99.2%   
CASH FLOW
From Operations Rs m340-266 -128.0%  
From Investments Rs m-127-1,907 6.6%  
From Financial Activity Rs m-1982,343 -8.5%  
Net Cashflow Rs m15170 9.0%  

Share Holding

Indian Promoters % 44.5 72.5 61.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 2.2 28.2%  
FIIs % 0.5 0.5 102.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 55.5 27.5 201.9%  
Shareholders   51,636 34,424 150.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KOPRAN. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on KOPRAN. vs GUFIC BIOSCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

KOPRAN. vs GUFIC BIOSCIENCE Share Price Performance

Period KOPRAN. GUFIC BIOSCIENCE S&P BSE HEALTHCARE
1-Day 4.62% -0.93% 1.18%
1-Month 4.47% -8.45% -0.75%
1-Year 162.07% 56.26% 61.82%
3-Year CAGR 36.17% 39.23% 18.16%
5-Year CAGR 45.30% 29.02% 19.79%

* Compound Annual Growth Rate

Here are more details on the KOPRAN. share price and the GUFIC BIOSCIENCE share price.

Moving on to shareholding structures...

The promoters of KOPRAN. hold a 44.5% stake in the company. In case of GUFIC BIOSCIENCE the stake stands at 72.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of KOPRAN. and the shareholding pattern of GUFIC BIOSCIENCE.

Finally, a word on dividends...

In the most recent financial year, KOPRAN. paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 53.1%.

GUFIC BIOSCIENCE paid Rs 0.1, and its dividend payout ratio stood at 1.2%.

You may visit here to review the dividend history of KOPRAN., and the dividend history of GUFIC BIOSCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.